TweeSteden Mild Stenosis Study

NCT ID: NCT01788241

Last Updated: 2015-10-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

547 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-01-31

Study Completion Date

2025-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Psychosocial factors have been found to be associated with an increased risk for coronary artery disease incidence, progression and worse clinical outcomes.

Patients with non-significant coronary artery disease (confirmed vascular irregularities, but \<60% coronary occlusion) often present with complaints such as chest pain, which warrant screening by coronary angiography (CAG) or computed tomography (CT scan). The prognosis of this group of patients with mild stenosis remains to be investigated in more detail, and we propose that psychosocial factors play a role in the clinical prognosis and patient reported outcomes in this group.

A special focus lies within examining personality characteristics, of which Type D personality is a primary predictor variable for prognosis. Type D personality is characterised by high negative affect and high social inhibition. In addition to psychosocial factors (personality, mood state, social support, SES), biomarkers(inflammation, clotting, DNA) as well as standard clinical risk factors (metabolic syndrome, activity level, smoking, medication use, disease severity) will be investigated.

The goal of the proposed study is to investigate a preexisting psycho-biochemical risk profile for major adverse cardiovascular events (MACE) and patient perceived symptoms in a group with angiographically or CT-scan confirmed, non-significant coronary artery disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease Non-significant Coronary Artery Disease Mild Stenosis Vascular Irregularities

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CAG and CT group

CAG group = patients included based on coronary angiography screening; CT group = patients included based on computed tomography screening

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Based on quantitative coronary angiography (CAG): visible, but non-significant (\<60% coronary occlusion) vascular irregularities and mild coronary stenosis.
* Based on 64-slice CT-scan (CT-scan): detected non-significant stenosis (calcium score \>= lowest 10th percentile), and not eligible for CAG.

Exclusion Criteria

* Normal coronary arteries (based on CAG or CT scan)
* Significant occlusion of coronary arteries (\>=60% stenosis)
* Eligible for coronary intervention such as PCI or CABG
* History of coronary events (being either MI,PCI, CABG, heart failure)
* For the CT-screened group: eligible for CAG based on the CT-scan
* Serious comorbid conditions such as chronic kidney failure, or receiving chemotherapy
* Insufficient knowledge of the Dutch language
Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Elisabeth-TweeSteden Hospital

OTHER

Sponsor Role collaborator

Elisabeth-TweeSteden Ziekenhuis

OTHER

Sponsor Role collaborator

Tilburg University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Paula M.C. Mommersteeg

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paula M.C. Mommersteeg, PhD

Role: PRINCIPAL_INVESTIGATOR

Tilburg University

Jos W. Widdershoven, MD PhD

Role: PRINCIPAL_INVESTIGATOR

The Elisabeth-TweeSteden Hospital

Wilbert Aarnoudse, MD PhD

Role: STUDY_CHAIR

The Elisabeth-TweeSteden Hospital

Johan Denollet, PhD

Role: STUDY_CHAIR

Tilburg University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

TweeSteden Hospital Tilburg

Tilburg, Dr. Deelenlaan 5, Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

References

Explore related publications, articles, or registry entries linked to this study.

Mommersteeg PM, Pot I, Aarnoudse W, Denollet J, Widdershoven JW. Type D personality and patient-perceived health in nonsignificant coronary artery disease: the TWeesteden mIld STenosis (TWIST) study. Qual Life Res. 2013 Oct;22(8):2041-50. doi: 10.1007/s11136-012-0340-2. Epub 2012 Dec 21.

Reference Type RESULT
PMID: 23263915 (View on PubMed)

Mommersteeg PM, Meeuwis SH, Denollet J, Widdershoven JW, Aarnoudse W, Westerhuis BL, Kop WJ. C-reactive protein and fibrinogen in non-obstructive coronary artery disease as related to depressive symptoms and anxiety: findings from the TweeSteden Mild Stenosis Study (TWIST). J Psychosom Res. 2014 Nov;77(5):426-9. doi: 10.1016/j.jpsychores.2014.09.020. Epub 2014 Oct 2.

Reference Type RESULT
PMID: 25307791 (View on PubMed)

Mommersteeg PM, Widdershoven JW, Aarnoudse W, Denollet J. Personality subtypes and chest pain in patients with nonobstructive coronary artery disease from the TweeSteden Mild Stenosis study: mediating effect of anxiety and depression. Eur J Pain. 2016 Mar;20(3):427-37. doi: 10.1002/ejp.743. Epub 2015 Jun 24.

Reference Type RESULT
PMID: 26105088 (View on PubMed)

Mommersteeg PMC, Naude PJW, Bagijn W, Widdershoven J, Westerhuis BWJJM, Schoemaker RG. Gender differences in associations of depressive symptoms and anxiety with inflammatory markers in patients with non-obstructive coronary artery disease. J Psychosom Res. 2019 Oct;125:109779. doi: 10.1016/j.jpsychores.2019.109779. Epub 2019 Jul 17.

Reference Type DERIVED
PMID: 31421324 (View on PubMed)

Mommersteeg PM, Arts L, Zijlstra W, Widdershoven JW, Aarnoudse W, Denollet J. Impaired Health Status, Psychological Distress, and Personality in Women and Men With Nonobstructive Coronary Artery Disease: Sex and Gender Differences: The TWIST (Tweesteden Mild Stenosis) Study. Circ Cardiovasc Qual Outcomes. 2017 Feb;10(2):e003387. doi: 10.1161/CIRCOUTCOMES.116.003387. Epub 2017 Feb 22.

Reference Type DERIVED
PMID: 28228453 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.tilburguniversity.edu/research/institutes-and-research-groups/corps/

CoRPS: Center of Research on Psychology in Somatic diseases. Primary funding for the TWIST study.

https://www.tweestedenziekenhuis.nl/

TweeSteden Hospital, Tilburg, the Netherlands. Study location and CoRPS collaboration \[Site in Dutch\]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UVT-MP-003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.